Brevan Howard Capital Management LP Corcept Therapeutics Inc Transaction History
Brevan Howard Capital Management LP
- $17 Billion
- Q3 2025
A detailed history of Brevan Howard Capital Management LP transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 3,341 shares of CORT stock, worth $252,379. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,341
Previous 45,002
92.58%
Holding current value
$252,379
Previous $3.3 Million
91.61%
% of portfolio
0.0%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding CORT
# of Institutions
480Shares Held
80.5MCall Options Held
596KPut Options Held
710K-
Black Rock Inc. New York, NY16.5MShares$1.25 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.54MShares$720 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.7MShares$582 Million20.92% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.09MShares$460 Million0.72% of portfolio
-
Parallel Advisors, LLC3.87MShares$292 Million6.09% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $8.09B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...